Table 1 Sequences of primers were used in this study
From: Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
Gene name | Sequence |
|---|---|
Caspase-3 | Forward: 5′-CAA ACT TTT TCA GAG GGG ATC G-3′ |
Reverse: 5′-GCA TAC TGT TTC AGC ATG GCA-3′ | |
Caspase-8 | Forward: 5′-CCC CAC CCT CAC TTT GCT-3′ |
Reverse: 5′-GGA GGA CCA GGC TCA CTT A-3′ | |
Caspase-9 | Forward: 5′-GGC CCT TCC TCG CTT CAT CTC-3′ |
Reverse: 5′-GGT CCT TGG GCC TTC CTG GTA T-3′ | |
Bax | Forward: 5′-AAG CTG AGC GAG TGT CTC CGG CG-3′ |
Reverse: 5′-CAG ATG CCG GTT CAG GTA CTC AGT C-3′ | |
Bcl-2 | Forward: 5′-CTC GTC GCT ACC GTC GTG ACT TGG-3′ |
Reverse: 5′-CAG ATG CCG GTT CAG GTA CTC AGT C-3′ | |
Bcl-xL | Forward: 5′-CCC AGA AAG GAT ACA GCT GG-3′ |
Reverse: 5′-GCG ATC CGA CTC ACC AAT AC-3′ | |
p53 | Forward: 5′-GCT CTG ACT GTA CCA CCA TCC-3′ |
Reverse: 5′-CTC TCG GAA CAT CTC GAA GCG-3′ | |
p21 | Forward: 5′-CTC AGA GGA GGC GCC ATG-3′ |
Reverse: 5′-GGG CGG ATT AGG GCT TCC-3′ | |
NF-κB | Forward: 5′-CAC TTA TGG ACA ACT ATG AGG TCT CTG G-3′ |
Reverse: 5′-CTG TCT TGT GGA CAA CGC AGT GGA ATT TTA GG-3′ | |
IκB-α | Forward: 5′-GCT GAA GAA GGA GCG GCT ACT-3′ |
Reverse: 5′-TCG TAC TCC TCG TCT TTC ATG GA-3′ | |
Fas | Forward: 5′-GAA ATG AAA TCC AAA GCT-3′ |
Reverse: 5′-TAA TTT AGA GGC AAA GTG GC-3′ | |
FasL | Forward: 5′-GGA TTG GGC CTG GGG ATG TTT CA-3′ |
Reverse: 5′-TTG TGG CTC AGG GGC AGG TTG TTG-3′ | |
TIMP-1 | Forward: 5′-GTC AGT GAG AAG CAA GTC GA-3′ |
Reverse: 5′-ATG TTC TTC TCT GTG ACC CA-3′ | |
TIMP-2 | Forward: 5′-TGG GGA CAC CAG AAG TCA AC-3′ |
Reverse: 5′-TTT TCA GAG CCT TGG AGG AG-3′ | |
MMP-2 | Reverse: 5′-CTT CTT CAA GGA CCG GTT CA-3′ |
Forward: 5′-GCT GGC TGA GTA CCA GTA-3′ | |
MMP-9 | Reverse: 5′-TGG GCT ACG TGA CCT ATG AC-3′ |
Forward: 5′-GCC CAG CCC ACC TCC ACT CC-3′ | |
HIAP-1 | Reverse: 5′-GCC TGA TGC TGG ATA ACT GG-3′ |
Forward: 5′-GGC GAC AGA AAA GTC AAT GG-3′ | |
HIAP-2 | Reverse: 5′-GCC TGA TGC TGG ATA ACT GG-3′ |
Forward: 5′-GCT CTT GCC AAT TCT GAT GG-3′ | |
COX-2 | Reverse: 5′-TTA AAA TGA GAT TGT CCG AA-3′ |
Forward: 5′-AGA TCA CCT CTG CCT GAG TA-3′ | |
iNOS | Reverse: 5′-AGA GAG ATC GGG TTC ACA-3′ |
Forward: 5′-CAC AGA ACT GAG GGT ACA-3′ | |
EGF | Reverse: 5′-GCC AAG CTC AGA AGG CTA C-3′ |
Forward: 5′-CAG GCC AGC CTC GTC TCA T-3′ | |
EGFR | Reverse: 5′-TCG GTG CTG TGC GAT TTA-3′ |
Forward: 5′-TTT CTG GCA GTT GCT CCT C-3′ | |
VEGF | Reverse: 5′-GCA CCC ATG GCA GAA GGA GGA G-3′ |
Forward: 5′-GTG CTG ACG CTA ACT GAC C-3′ | |
Fit-1 | Reverse: 5′-CAA GTG GCCAGA GGC ATG GAG TT-3′ |
Forward: 5′-GAT GTA GTC TTTACC ATC CTG TTG-3′ | |
GAPDH | Reverse: 5′-CGG AGT CAA CGG ATT TGG TC-3′ |
Forward: 5′-AGC CTT CTC CAT GGT CGT GA-3′ |